日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Innovation

Hong Kong medicine scholars develop innovative targeted delivery system for treating bone tumor

Xinhua | Updated: 2017-11-09 17:19

HONG KONG - China's Hong Kong Baptist University (HKBU) announced Thursday that its medicine scholars have succeeded in developing a novel targeted delivery system for CRISPR/Cas9 to achieve therapeutic genome editing of VEGFA in osteosarcoma (OS).

Their research paper, entitled "Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalised lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma", was recently published in the internationally renowned academic journal Biomaterials.

CRISPR/Cas9 is a budding genome editing technology which holds tremendous promise for cancer treatment. However, a major bottleneck for achieving the therapeutic potential of CRISPR/Cas9 is the lack of an in vivo targeted delivery system.

The HKBU team has achieved a breakthrough in the search for an answer to the crux of the above mentioned problem and developed an aptamer-functionalised delivery system for CRISPR/Cas9 with the treatment of OS as a research target.

The research team is led by Professor Lyu Aiping, dean of the School of Chinese Medicine (SCM) of HKBU, and Professor Zhang Ge, Director of Technology Development Division and Associate Director of Teaching and Research Division of SCM.

"OS, a very common primary malignant bone tumor in children and adolescents, is mainly treated by surgery and chemotherapy, but the five-year post-surgery survival rate is a mere 5 percent to 20 percent," Zhang said, "Aptamers which are single-stranded oligonucleotides and could specifically recognize target cells have been widely used for in vivo targeted delivery of therapeutics. VEGFA has been reported to be a novel therapeutic target for OS."

Lyu said,"The tumor-specific aptamers, when conjugated with PPC polymers encapsulating CRISPR/Cas9, may facilitate therapeutic genome editing in tumors."

In the experiments using a mouse model, the aptamer facilitated selective distribution of CRISPR/Cas9 in both orthotopic OS and lung metastasis, leading to effective in vivo VEGFA genome editing, inhibited orthotopic OS malignancy and lung metastasis, as well as reduced angiogenesis and bone lesion with no detectable toxicity. The research facilitated clinical application of CRISPR/Cas9 in tumor treatment.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 在线观看毛片视频 | 国产精品一卡二卡三卡 | 国产在线精品一区二区 | 国产精品啪一品二区三区粉嫩 | 香蕉视频在线观看免费 | 91久久久久久久久久久久久久 | 欧美一级二级三级 | 久久se精品一区精品二区 | 九色国产 | 天天操天天插天天干 | 精品国产自在2o18 | 99r精品在线| 国产精品人妻无码久久久郑州 | 日韩中文字幕在线看 | 免费av大全| 99国产在线视频有精品视频 | 亚洲精品久久久久久一区 | 操久久久 | 一级肉体aa电影 | 国产乱码在线观看 | 亚洲香蕉毛片久久网站老妇人 | 超碰在线观看97 | 欧美亚洲高清 | 亚洲高清免费视频 | 国产精品夜夜春夜夜爽久久 | 国产成年人网站 | 亚洲欧美日韩中文综合在线不卡 | 久久久久国产成人精品亚洲午夜 | 欧美激情欧美激情在线五月 | 日产精品卡二卡三卡四卡乱码视频 | 在线欧美 | 天天视频网站 | 久操久热| 欧美亚洲理伦电影毛片在线播放 | 日韩a视频 | 国产一区二区精品在线观看 | 偷自拍第一页 | 国产精品亚洲综合 | 欧美激情a∨在线视频播放 中文字幕亚洲图片 | 日韩一级片在线免费观看 | 99re6在线视频精品免费 |